NCT07013513Not yet recruiting
Characterising Physiological Resilience in People With Parkinson's Disease
Characterising the Physiological Resilience of People With Parkinson's Disease - With Feasibility
Source: ClinicalTrials.gov · Last updated 10 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Parkinson's disease (PD) is a condition that affects movement and gets worse over time. It is more common in older adults. People with PD may have symptoms like shaking, stiff muscles, slow movement, and trouble with balance. They may also experience other issues like pain, depression, anxiety, and memory problems, which can make daily life harder. Physiological resilience is the body's ability to recover or stay strong despite challenges like aging or illness. People with low resilience may struggle to cope with illness, become less active, and have a higher risk of weakness or hospitalization. Since both PD and low resilience are more common in older adults, understanding how PD affects resilience can help improve care. This study will look at resilience in people with PD by measuring heart, lung, muscle, coordination, memory, and thinking abilities. It will also compare two types of single-session aerobic exercise-cycling and walking on a treadmill-regarding participants' perspectives. Participants will be randomly chosen to do one of these exercises for 40 minutes at a moderate level. Afterward, they will share their thoughts on how enjoyable and comfortable the exercise was and whether they would continue doing it. Aerobic exercise is often recommended for people with PD, but it is unclear which type is best for people with PD and which type is mostly preferred by participants with PD. The results of this study will help practitioners make better exercise recommendations for people with PD, leading to better symptom management and a higher quality of life.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 16 (estimated)
- First submitted
- 1 Jun 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- University of Nottingham
- Diseases
- Parkinson disease
- NCT number
- NCT07013513
What you commit to
- Study type: Observational
- Planned participants: 16
- From 1 Jun 2025 to the primary completion date, 1 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or recent (\<2 years) malignancy (excluding minor cancers such as skin cancer, or not receiving chemotherapy or radiotherapy within the last 3 months)
Other illness
- Cardio- and/or pulmonary diseases except for well-controlled hypertension and asthma
- Severe cognitive impairment/dementia
- Joint disorders preventing exercise participation
Who the study is looking for
- Participants who are willing and able to give informed consent for participation in the study
- Participants who can walk 30 meters with or without walking aids
- Participants who have a confirmed diagnosis of Parkinson's disease by a healthcare professional.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Nottingham/Medical School Coordinator of this site? Confirm its status | Derby | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.